Best for Post-acne marks

Systematic review of keratolytics and emollients in psoriasis therapy: salicylic acid is a key keratolytic that removes psoriatic scale and improves penetration of co-applied topical agents; supports salicylic acid as an evidence-based adjunctive (descaling) treatment rather than a standalone therapy.

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Review confirms dermal HA declines ~50% by age 70; topical HA penetration is MW-dependent (fragments <50 kDa penetrate deeper but may paradoxically stimulate inflammation); multi-weight formulations balance hydration and penetration depth

Comprehensive review: salicylic acid (2%) is the only lipophilic BHA, enabling comedolytic and anti-inflammatory activity within the pilosebaceous unit; effective for acne vulgaris, melasma, photodamage, and keratosis pilaris; 20-30% SA peels show efficacy comparable to glycolic acid peels with lower erythema risk in Fitzpatrick IV-VI

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

This review of four placebo-controlled clinical studies and a comedolytic assay found that 0.5% and 2% salicylic acid pads reduced the number and severity of acne lesions in mild-to-moderate acne vulgaris. Comparative data showed salicylic acid superior to benzoyl peroxide, with adverse effects limited to mild local irritation.

Single-blind RCT (n=46, 12 weeks) in mild-to-moderate acne comparing salicylic acid 3% plus clindamycin with tretinoin 0.05% plus clindamycin: both significantly reduced inflammatory and non-inflammatory lesion counts; tretinoin acted faster (significant by week 2) but groups were comparable at 12 weeks, and both were well tolerated.

Randomized controlled trial (8 weeks): Acne efficacy vs topical antibiotic.

Randomized controlled trial: Independent replication of melanosome transfer mechanism and reversibility.

Topical 0.1% hyaluronic acid creams of five molecular weights (50-2000 kDa) significantly improved skin hydration and elasticity versus placebo in 76 women. Low-molecular-weight HA (50 and 130 kDa) significantly reduced periocular wrinkle depth after 60 days, suggesting better skin penetration of smaller HA molecules.

Clinical review of fragrance contact allergy: an estimated 1.7-4.1% of the general population is sensitized to fragrance-mix ingredients and about 10% of patch-tested eczema patients react; fragrance materials occur in 15-100% of cosmetic products; allergy predominates in women with facial or hand eczema.

Systematic review of keratolytics and emollients in psoriasis therapy: salicylic acid is a key keratolytic that removes psoriatic scale and improves penetration of co-applied topical agents; supports salicylic acid as an evidence-based adjunctive (descaling) treatment rather than a standalone therapy.

Review of ethanol effects on skin: ethanol disrupts the stratum corneum lipid bilayer in a dose-dependent manner, increases TEWL, and extracts intercellular ceramides; at concentrations >30% (common in toners and astringents), causes measurable barrier dysfunction within 30 minutes of application

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Comprehensive review: salicylic acid (2%) is the only lipophilic BHA, enabling comedolytic and anti-inflammatory activity within the pilosebaceous unit; effective for acne vulgaris, melasma, photodamage, and keratosis pilaris; 20-30% SA peels show efficacy comparable to glycolic acid peels with lower erythema risk in Fitzpatrick IV-VI

Applied EU CLP hazard-classification criteria (EC 1272/2008) to personal care products: nearly all contained ingredients that would trigger hazard labelling—85% for eye effects and 52% for skin effects (including sensitizers such as fragrance allergens)—yet cosmetics are exempt from CLP labelling, leaving consumers under-informed about these hazards.

Systematic review establishing fragrance as the leading cause of cosmetic contact dermatitis, responsible for 30-45% of cosmetic adverse reactions; covers both irritant (direct keratinocyte damage) and allergic (hapten-driven type IV hypersensitivity) mechanisms; identifies cinnamal, hydroxycitronellal, and oakmoss as top individual allergens

Controlled human irritation study: alcohols (notably ethanol) showed low irritation potential, producing no significant barrier disruption or erythema even when applied to skin pre-irritated with the detergent SLS; indicates alcohol is a comparatively weak skin irritant rather than a major barrier-damaging agent.

Clinical review of fragrance contact allergy: an estimated 1.7-4.1% of the general population is sensitized to fragrance-mix ingredients and about 10% of patch-tested eczema patients react; fragrance materials occur in 15-100% of cosmetic products; allergy predominates in women with facial or hand eczema.

Systematic review of keratolytics and emollients in psoriasis therapy: salicylic acid is a key keratolytic that removes psoriatic scale and improves penetration of co-applied topical agents; supports salicylic acid as an evidence-based adjunctive (descaling) treatment rather than a standalone therapy.

Applied EU CLP hazard-classification criteria (EC 1272/2008) to personal care products: nearly all contained ingredients that would trigger hazard labelling—85% for eye effects and 52% for skin effects (including sensitizers such as fragrance allergens)—yet cosmetics are exempt from CLP labelling, leaving consumers under-informed about these hazards.

Systematic review establishing fragrance as the leading cause of cosmetic contact dermatitis, responsible for 30-45% of cosmetic adverse reactions; covers both irritant (direct keratinocyte damage) and allergic (hapten-driven type IV hypersensitivity) mechanisms; identifies cinnamal, hydroxycitronellal, and oakmoss as top individual allergens

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Comprehensive review: salicylic acid (2%) is the only lipophilic BHA, enabling comedolytic and anti-inflammatory activity within the pilosebaceous unit; effective for acne vulgaris, melasma, photodamage, and keratosis pilaris; 20-30% SA peels show efficacy comparable to glycolic acid peels with lower erythema risk in Fitzpatrick IV-VI

Review confirms dermal HA declines ~50% by age 70; topical HA penetration is MW-dependent (fragments <50 kDa penetrate deeper but may paradoxically stimulate inflammation); multi-weight formulations balance hydration and penetration depth

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

RCT (n=197 atopic dermatitis patients): a 20% glycerin cream, its glycerin-free base, and a 4% urea/4% NaCl cream were applied daily for 30 days. Glycerin and the comparators had equal effects on skin dryness; glycerin caused significantly less smarting than the urea-saline cream (10% vs 24%, p<0.0006).

Bilateral double-blind study (n=17): a cream containing 20% glycerin significantly increased skin hydration (corneometer) versus its vehicle, but did not significantly affect transepidermal water loss or skin sensitivity to sodium lauryl sulfate-induced irritation—glycerin's benefit was on hydration, not barrier function.

Placebo-controlled, double-blind RCT (n=24, atopic dermatitis): a glycerol-based emollient applied twice daily for 4 weeks significantly improved stratum corneum hydration and restored epidermal barrier function versus a glycerol-free placebo; no significant differences from placebo were found for erythema, SCORAD, or local severity scores.

Randomized controlled trial (8 weeks): Acne efficacy vs topical antibiotic.

Randomized controlled trial: Independent replication of melanosome transfer mechanism and reversibility.

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Review confirms dermal HA declines ~50% by age 70; topical HA penetration is MW-dependent (fragments <50 kDa penetrate deeper but may paradoxically stimulate inflammation); multi-weight formulations balance hydration and penetration depth

RCT (n=197 atopic dermatitis patients): a 20% glycerin cream, its glycerin-free base, and a 4% urea/4% NaCl cream were applied daily for 30 days. Glycerin and the comparators had equal effects on skin dryness; glycerin caused significantly less smarting than the urea-saline cream (10% vs 24%, p<0.0006).

Bilateral double-blind study (n=17): a cream containing 20% glycerin significantly increased skin hydration (corneometer) versus its vehicle, but did not significantly affect transepidermal water loss or skin sensitivity to sodium lauryl sulfate-induced irritation—glycerin's benefit was on hydration, not barrier function.

Placebo-controlled, double-blind RCT (n=24, atopic dermatitis): a glycerol-based emollient applied twice daily for 4 weeks significantly improved stratum corneum hydration and restored epidermal barrier function versus a glycerol-free placebo; no significant differences from placebo were found for erythema, SCORAD, or local severity scores.

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

Systematic review: Breastfeeding nipple pain evidence consolidation including panthenol as lanolin alternative.

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Review confirms dermal HA declines ~50% by age 70; topical HA penetration is MW-dependent (fragments <50 kDa penetrate deeper but may paradoxically stimulate inflammation); multi-weight formulations balance hydration and penetration depth

Systematic review of topical vitamin C for melasma and photoaging: concludes topical ascorbic acid improves photoaging signs (fine lines, roughness, pigmentation) and contributes to melasma lightening, supporting its use as an antioxidant/depigmenting agent, while formulation instability/oxidation and study heterogeneity limit firm conclusions.

Double-blind, vehicle-controlled, 6-month trial: 5% vitamin C cream significantly improved clinical photoaging score; punch biopsies confirmed increased type I and type III collagen mRNA and protein, plus decreased MMP-1; one of the few biopsy-proven vitamin C studies

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

RCT (n=197 atopic dermatitis patients): a 20% glycerin cream, its glycerin-free base, and a 4% urea/4% NaCl cream were applied daily for 30 days. Glycerin and the comparators had equal effects on skin dryness; glycerin caused significantly less smarting than the urea-saline cream (10% vs 24%, p<0.0006).

Bilateral double-blind study (n=17): a cream containing 20% glycerin significantly increased skin hydration (corneometer) versus its vehicle, but did not significantly affect transepidermal water loss or skin sensitivity to sodium lauryl sulfate-induced irritation—glycerin's benefit was on hydration, not barrier function.

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Review confirms dermal HA declines ~50% by age 70; topical HA penetration is MW-dependent (fragments <50 kDa penetrate deeper but may paradoxically stimulate inflammation); multi-weight formulations balance hydration and penetration depth

Systematic review of topical vitamin C for melasma and photoaging: concludes topical ascorbic acid improves photoaging signs (fine lines, roughness, pigmentation) and contributes to melasma lightening, supporting its use as an antioxidant/depigmenting agent, while formulation instability/oxidation and study heterogeneity limit firm conclusions.

Double-blind, vehicle-controlled, 6-month trial: 5% vitamin C cream significantly improved clinical photoaging score; punch biopsies confirmed increased type I and type III collagen mRNA and protein, plus decreased MMP-1; one of the few biopsy-proven vitamin C studies

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

RCT (n=197 atopic dermatitis patients): a 20% glycerin cream, its glycerin-free base, and a 4% urea/4% NaCl cream were applied daily for 30 days. Glycerin and the comparators had equal effects on skin dryness; glycerin caused significantly less smarting than the urea-saline cream (10% vs 24%, p<0.0006).

Bilateral double-blind study (n=17): a cream containing 20% glycerin significantly increased skin hydration (corneometer) versus its vehicle, but did not significantly affect transepidermal water loss or skin sensitivity to sodium lauryl sulfate-induced irritation—glycerin's benefit was on hydration, not barrier function.

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

RCT (n=197 atopic dermatitis patients): a 20% glycerin cream, its glycerin-free base, and a 4% urea/4% NaCl cream were applied daily for 30 days. Glycerin and the comparators had equal effects on skin dryness; glycerin caused significantly less smarting than the urea-saline cream (10% vs 24%, p<0.0006).

Bilateral double-blind study (n=17): a cream containing 20% glycerin significantly increased skin hydration (corneometer) versus its vehicle, but did not significantly affect transepidermal water loss or skin sensitivity to sodium lauryl sulfate-induced irritation—glycerin's benefit was on hydration, not barrier function.

Placebo-controlled, double-blind RCT (n=24, atopic dermatitis): a glycerol-based emollient applied twice daily for 4 weeks significantly improved stratum corneum hydration and restored epidermal barrier function versus a glycerol-free placebo; no significant differences from placebo were found for erythema, SCORAD, or local severity scores.

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

RCT in pediatric AD (n=24, ages 2-9): ceramide-dominant barrier repair lipid applied for 12 weeks significantly improved SCORAD scores (p<0.01), reduced TEWL, and normalized stratum corneum lamellar structure on electron microscopy; parents reported reduced pruritus and sleep disturbance

Randomized controlled trial (8 weeks): Acne efficacy vs topical antibiotic.

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

RCT (n=197 atopic dermatitis patients): a 20% glycerin cream, its glycerin-free base, and a 4% urea/4% NaCl cream were applied daily for 30 days. Glycerin and the comparators had equal effects on skin dryness; glycerin caused significantly less smarting than the urea-saline cream (10% vs 24%, p<0.0006).

Bilateral double-blind study (n=17): a cream containing 20% glycerin significantly increased skin hydration (corneometer) versus its vehicle, but did not significantly affect transepidermal water loss or skin sensitivity to sodium lauryl sulfate-induced irritation—glycerin's benefit was on hydration, not barrier function.

Placebo-controlled, double-blind RCT (n=24, atopic dermatitis): a glycerol-based emollient applied twice daily for 4 weeks significantly improved stratum corneum hydration and restored epidermal barrier function versus a glycerol-free placebo; no significant differences from placebo were found for erythema, SCORAD, or local severity scores.

Randomized controlled trial (8 weeks): Acne efficacy vs topical antibiotic.

Randomized controlled trial: Independent replication of melanosome transfer mechanism and reversibility.

Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons

Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations

Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.

Mechanistic review: niacinamide inhibits melanosome transfer via PAR-2 downregulation, upregulates ceramide and fatty acid synthesis for barrier repair, and reduces TEWL; Korean government-funded with no industry conflicts; notes most clinical trials are industry-sponsored

Review confirms dermal HA declines ~50% by age 70; topical HA penetration is MW-dependent (fragments <50 kDa penetrate deeper but may paradoxically stimulate inflammation); multi-weight formulations balance hydration and penetration depth

RCT (n=197 atopic dermatitis patients): a 20% glycerin cream, its glycerin-free base, and a 4% urea/4% NaCl cream were applied daily for 30 days. Glycerin and the comparators had equal effects on skin dryness; glycerin caused significantly less smarting than the urea-saline cream (10% vs 24%, p<0.0006).

Bilateral double-blind study (n=17): a cream containing 20% glycerin significantly increased skin hydration (corneometer) versus its vehicle, but did not significantly affect transepidermal water loss or skin sensitivity to sodium lauryl sulfate-induced irritation—glycerin's benefit was on hydration, not barrier function.

Placebo-controlled, double-blind RCT (n=24, atopic dermatitis): a glycerol-based emollient applied twice daily for 4 weeks significantly improved stratum corneum hydration and restored epidermal barrier function versus a glycerol-free placebo; no significant differences from placebo were found for erythema, SCORAD, or local severity scores.

Niacinamide 4% comparable to hydroquinone 4% for melasma treatment (MASI reduction 43% vs 55%, p=ns); niacinamide showed significantly fewer side effects (0% vs 18% irritation); independently funded with no industry involvement

Systematic review: Breastfeeding nipple pain evidence consolidation including panthenol as lanolin alternative.